Stay updated on Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Prasinezumab in Early Parkinson's Disease Clinical Trial page
- Check3 days agoChange DetectedOn 2026-01-09, the record history shows updates to Contacts/Locations and Study Status. The update is associated with Revision: v3.3.4, with a prior Revision: v3.3.3 removed on 2025-09-30.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new 'Revision: v3.3.3' tag appears; the 'HHS Vulnerability Disclosure' link and the older 'Revision: v3.3.2' label were removed.SummaryDifference0.1%

- Check53 days agoChange DetectedRecord History shows an added Revision: v3.3.2 and removed Revision: v3.2.0, with no substantive changes to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe government funding lapse notice on the page has been removed. All other trial-related content and layout appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedThe new screenshot shows cosmetic UI changes to the Record History page (layout, header spacing, and visual elements) while the underlying version data and listed records remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check104 days agoChange DetectedUpdated page notices and status details, including a new revision tag v3.2.0 with a 2025-09-30 date, replacing the old v3.1.0 (2025-07-08). Also added government funding lapse notice and operating status links.SummaryDifference10%

Stay in the know with updates to Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.